https://charts.traderzeitung.de/phases/US82835W1080
string(1460) "{"isin":"US82835W1080","name":"ARS Pharmaceuticals Inc","stock_id_xnas":16776262,"stock_id_xnys":null,"generated_at":"2026-07-28 06:05:00","days":[{"date":"2026-07-23","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":6.06,"close_at":"2026-07-23 15:28:00","complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":5.995,"close_at":"2026-07-23 21:59:00","complete":true,"perf_pct":-1.0726},{"phase":3,"label":"post","from":"22:00","to":"24:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-07-24","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":6.16,"close_at":"2026-07-24 14:05:00","complete":true,"perf_pct":2.7523},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":5.93,"close_at":"2026-07-24 21:59:00","complete":true,"perf_pct":-3.7338},{"phase":3,"label":"post","from":"22:00","to":"24:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-07-27","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":6.175,"close_at":"2026-07-27 15:23:00","complete":true,"perf_pct":4.1315},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":5.745,"close_at":"2026-07-27 21:59:00","complete":true,"perf_pct":-6.9636},{"phase":3,"label":"post","from":"22:00","to":"24:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]}]}"
ARS Pharmaceuticals Aktie News & Nachrichten

ARS Pharmaceuticals Aktie News & Nachrichten

[WKN: A2QHK9 | Symbol: SBTX]
Realtimekurs
   
Vorbörsliche Indikationen
Regulärer Handel
Nachbörslicher Handel
ARS Pharmaceuticals Chart

Artikel aus der Redaktion der Trader-Zeitung

Silverback Therapeutics: Von der Nische zur Milliardenchance?

Silverback Therapeutics ist ein klinisch orientiertes Biotechnologieunternehmen mit Sitz in Seattle,...

  • 1
MT Newswires 07.07.2026 23:03 Uhr

ARS Pharmaceuticals ernennt Donn Casale zum CEO, da Richard Lowenthal ausscheidet

05:02 PM EDT, 07/07/2026 (MT Newswires) -- Der Vorstand von ARS Pharmaceuticals (SPRY) hat Präsident Donn Casale mit sofortiger Wirkung zum Chief Exec

MT Newswires 25.06.2026 13:42 Uhr

Top Premarket-Verlierer

07:40 AM EDT, 06/25/2026 (MT Newswires) -- Die Aktien von Elme Communities (ELME) fielen im Premarket-Handel am Donnerstag um 23%, nachdem das Unterne

MT Newswires 25.06.2026 12:49 Uhr

ARS Pharmaceuticals aktualisiert Neffy-Abdeckungsaussichten, senkt Kosten für 2026

06:48 AM EDT, 06/25/2026 (MT Newswires) -- ARS Pharmaceuticals (SPRY) teilte am späten Mittwoch mit, dass im Zyklus vom 1. Juli keine neuen kommerziel